Tomocube, Inc. (475960.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩31,400 (+0.16%) as of
Key statistics
- Market cap
- 420.23B
- Forward P/E
- 28.26
- Dividend yield
- 0.00%
- 52-week range
- 26,000.00 – 67,800.00
- Revenue (TTM)
- 15.22B
- Profit margin
- -16.11%
- Volume
- 37.37k
About Tomocube, Inc.
Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibration isolation system that enables users to capture images in a stable environment; and vessel holders, environmental controllers, and 3D controllers. The company was founded in 2015 and is headquartered in Daejeon, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Daejeon, South Korea
- Employees
- 66
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.